Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Steris (NYSE: STE ) �-- a manufacturer of infection prevention, contamination control, and surgical support products for the health-care industry -- jumped as much as 10% after reporting better-than-expected fourth-quarter results.
So what: For the quarter, Steris' shareholders witnessed revenue increase by 10% to $428.2 million as EPS shrank modestly to $0.70 from $0.76 in the year-ago period. Although Steris blamed European weakness and the medical device excise tax for its weaker bottom-line results, both figures topped the $406 million in revenue and $0.65 in EPS that the Street had been expecting. The biggest boost came from the company's life sciences segment, which saw operating income grow by 14%. For the upcoming year, Steris issued guidance calling for revenue growth of 8%-10% (implying $1.62 billion to $1.65 billion) and EPS of $2.47-$2.60. Current consensus estimates are for revenue of $1.57 billion and EPS of $2.49.
Best Life Sciences Stocks To Buy Right Now: Goldcorp Incorporated(GG)
Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. It produces and sells gold, silver, copper, lead, and zinc. The company was founded in 1954 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Sean Williams]
One lustrous investment
If you hadn't guessed by now, I'm a big fan of gold and gold miners. There are multiple factors at the moment that I feel could usher in another rally in gold prices. These include weak global economies, which make gold an attractive safe-haven investment; low domestic interest rates, which make gold attractive relative to low-yielding CDs and bonds; copious U.S. money printing, which could lead to inflation; and a contrarian mentality to buy when others are fearful. That's why I think investors would be foolish to pass up on cost-efficiency mining expert Goldcorp (NYSE: GG ) at its current levels. - [By GURUFOCUS]
Goldcorp Inc. (GG) engages in the acquisition, development, exploration, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. Yield: 2.5%
Best Life Sciences Stocks To Buy Right Now: PetroLogistics LP (PDH)
PetroLogistics LP owns and operates propane dehydrogenation (PDH) facility. The Company is located in the vicinity of the Houston Ship Channel. As of April 23, 2012, the Company had an annual production capacity of approximately 1.45 billion pounds of propylene. Its PDH facility uses a CATOFIN dehydrogenation technology pursuant to a fully-paid license from CB&I Lummus. It derives its sales from three different sources: propylene sales, hydrogen sales, and mixed stream of butane and butylenes (C4 mix stream) and heavier hydrocarbons (C5+ stream) sales.
Contracted Propylene Sales
The Company has propylene sales contracts with The Dow Chemical Company (Dow), Total Petrochemicals USA, Inc. (Total), and INEOS Olefins and Polymers USA (INEOS), each of which use the propylene it supplies in the acrylic acid, polypropylene and acrylonitrile plants. Effective January 1, 2012, it added BASF Corporation (BASF) and LyondellBasell Industries N.V. (LyondellBasell) as additional contracted customers. It delivers propylene to these customers through its integrated pipeline system, which connects its facility to the Dow and Total plants and the LyondellBasell system, and through interconnected third-party pipelines, which connect its facility to INEOS and BASF and to other potential propylene customers.
Spot-Market Propylene Sales
Through the Company�� integrated pipeline system, the Company accesses other consumers of propylene, which it is able to supply on a spot basis with its excess production capacity. It manages its contract and spot portfolio.
Hydrogen Gas Sales
As part of the PDH process, the Company produces commercial quantities of hydrogen. Hydrogen is consumed in refinery processes, including fuel desulphurization.
C4 Mix/C5+ Streams Sales
The Company produces commercial quantities of C4 mix/C5+ streams. It sells the C4 mix stream to specialty chemical consumers or refiners and these customers tran! sport the purchased volumes from its facility by truck. The C5+ stream, which is heavy in aromatics, is transported by its pipeline to a Kinder Morgan terminal, and then sold to Texas Aromatics for use in the chemical or gasoline markets.
The Company competes with Enterprise, Chevron Phillips, ExxonMobil Chemical, Shell Chemical, Flint Hills and the Williams Companies.
Advisors' Opinion:- [By Seth Jayson]
PetroLogistics (NYSE: PDH ) reported earnings on July 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), PetroLogistics met expectations on revenues and beat expectations on earnings per share.
5 Best Logistics Stocks To Own Right Now: Corrections Corporation of America (CXW)
Corrections Corporation of America (CCA) incorporated on September 24, 1998, is a real estate investment trust. The Company is the owner of privatized correctional and detention facilities and prison operators in the United States. As of December 31, 2012, the Company operated 67 correctional and detention facilities, including 47 facilities that the Company own, with a total design capacity of approximately 92,500 beds in 20 states and the District of Columbia. Beginning of January 1, 2013, the Company has provided correctional services and conducted other operations through TRSs. A TRS is a subsidiary of a REIT that is subject to applicable corporate income tax and certain qualification requirements. In January 2012, the Company closed the operations of the 1,172-bed Delta Correctional Facility in Greenwood, Mississippi. In January 2013, the Company announced that it has completed an internal reorganization of its business operations.
The Company specializes in owning, operating, and managing prisons and other correctional facilities and providing inmate residential and prisoner transportation services for governmental agencies. In addition to providing the fundamental residential services relating to inmates, its facilities offer a variety of rehabilitation and educational programs, including basic education, religious services, life skills and employment training and substance abuse treatment. These services are intended to help reduce recidivism and to prepare inmates for their re entry into society upon their release. The Company also provides health care (including medical, dental, and mental health services), food services, and work and recreational programs.
The Company�� customers consist of federal, state and local correctional and detention authorities. During the year ended December 31, 2012, federal correctional and detention authorities represented 43% of its total revenue. Federal correctional and detention authorities primarily consist of the Federal Burea! u of Prisons (BOP), the United States Marshals Service (USMS), and the United States Immigration and Customs Enforcement (ICE). Its management services contracts typically have terms of three to five years and contain multiple renewal options. Its facility contracts also contain clauses that allow the government agency to terminate the contract at any time without cause, and its contracts are generally subject to annual or bi-annual legislative appropriations of funds.
The Company is compensated for providing prison bed capacity and correctional services at an inmate per diem rate based upon actual or minimum guaranteed occupancy levels. Occupancy rates for a particular facility are typically low when opened or immediately following an expansion. However, beyond the start-up period, which typically ranges from 90 to 180 days, the occupancy rate tends to stabilize. During 2012, the average compensated occupancy of its facilities, based on rated capacity, was 88.2% for all of the facilities it owned or managed, exclusive of facilities where operations have been discontinued.
The Company provides a variety of rehabilitative and educational programs at its facilities. Inmates at facilities the Company manage may receive basic education through academic programs designed to improve literacy levels and the opportunity to acquire GED certificates. The Company also offers vocational training to inmates who lack marketable job skills. Its craft vocational training programs are accredited by the National Center for Construction Education and Research. This foundation provides training curriculum and establishes industry standards for over 4,000 construction and trade organizations in the United States and several foreign countries. In addition, the Company offers life skills transition-planning programs that provide inmates with job search skills, health education, financial responsibility training, parenting training, and other skills associated with becoming productive citizens.
! As of December 31, 2012, the Company provides transportation services to governmental agencies through its wholly owned TRS, TransCor America, LLC, or TransCor. CCA owns 49 correctional and detention facilities in 15 states and the District of Columbia, two of which it leases to third-party operators. The Company also owns two corporate office buildings. Additionally, it manages 20 correctional and detention facilities owned by government agencies. Owned and managed facilities include facilities placed into service that the Company owned and managed. Managed-only facilities include facilities owned by a third party and managed by the Company.
The Company competes with The GEO Group, Inc. and Management and Training Corporation.
Advisors' Opinion:- [By Sean Williams]
The premise here would be that any increase in nationwide drug testing would be bound to turn up additional drug users and could boost the prison population. That would be great news for the GEO Group (NYSE: GEO ) and Corrections Corp. of America (NYSE: CXW ) , which are contracted out through the government to run and service prisons around the country.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Corrections Corporation of America (NYSE: CXW ) , whose recent revenue and earnings are plotted below. - [By Rich Smith]
Nashville, Tenn.-based Corrections Corporation of America (NYSE: CXW ) has won a contract extension from the California Department of Corrections, the company announced Wednesday, extending its contract length by three years.
Best Life Sciences Stocks To Buy Right Now: Regeneron Pharmaceuticals Inc.(REGN)
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.
Advisors' Opinion:- [By Dan Caplinger]
Regeneron Pharmaceuticals (NASDAQ: REGN ) , up 55%
Interestingly enough, part of the reason for Regeneron's big advance comes from the fact that it wasn't even part of the S&P 500 until a couple weeks ago. The biotech company came into the index at the end of April, replacing MetroPCS after its merger with T-Mobile. Yet even after that, Regeneron's stock has soared 27%, largely because of the misfortunes of rival Allergan and its failed phase 2 study of competing vision-loss drug candidate DARPin. The move should pave the way for Regeneron's Eylea to enjoy even faster growth.
Best Life Sciences Stocks To Buy Right Now: Fujitsu Ltd (FJTSY)
Fujitsu Limited (Fujitsu), incorporated on June 20, 1935, is engaged in providing solutions in the field of information and communication technology. Along with multifaceted services provision, its business consists of the development, manufacture, sales and maintenance of the high-quality products and electronic devices that make these services possible. The Company operates in three segments: technology solutions, ubiquitous products solutions and device solutions. On June 4, 2009, Fujitsu introduced the docomo PRIME series F-09A mobile handset. On July 15, 2009, Fujitsu announces acquisition of shares in information technology (IT) subsidiary of AUTOBACS SEVEN. In October 2010, the Company and Toshiba Corporation announced that they have completed the merger of their mobile phone businesses. Effective August 15, 2013, Intel Corp acquired Fujitsu Semiconductor Wireless Products Inc, from Fujitsu Semiconductor Ltd, a wholly owned subsidiary of Fujitsu Ltd.
Technology solutions
Fujitsu provides solutions/system integration services focused on information system consulting and integration, and infrastructure services centered on outsourcing services (complete information system operation and management). Fujitsu offers system products, such as servers and storage systems, which form the backbone of information systems, along with network products, such as mobile phone base stations, optical transmission systems and other communications infrastructures. Its services include system integration (system construction), consulting, front-end technologies (automated teller machines (ATMs)), outsourcing services (datacenters, IT operation/management, software as a service (SaaS), application operation/management and business process outsourcing), network services (business networks, distribution of Internet/mobile content), system support services (maintenance and surveillance services for information systems and networks) and security solutions (installation of information systems an! d networks).
Ubiquitous products solutions
Fujitsu offers the personal computers (PCs), mobile phones and other products indispensable for realizing the emerging ubiquitous networked society. In PCs, along with more conventional desktop and notebook models, the Company develops netbooks and products with security features, providing a global lineup that allows customers to choose the product for their application. In mobile phones, it provide a variety of products that include high-performance models featuring specs and water resistance, separable mobile phone handset, and products created from collaborations with brands. Its products include PCs, mobile phones and optical transceiver modules.
Device solutions
LSI devices and electronic components comprise Fujitsu�� Device Solutions. Fujitsu Semiconductor, the Fujitsu operating company in semiconductors, provides LSI devices found in products, such as digital home appliances, automobiles, mobile phones and servers. The Company�� subsidiaries Shinko Electric Industries Co., Ltd. and Fujitsu Component Limited, along with FDK Corporation, provide semiconductor packages and other electronic components, as well as structural components, such as batteries, relays and connectors. Its products include LSI devices, electronic components (semiconductor packages), batteries and structural components (relays and connectors).
Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks rose in early Monday trading, with weaker-than-expected trade data pushing the yen lower, which in turn helped some export stocks. The Nikkei Stock Average (JP:NIK) added 1% to 14,704.36, with the broader Topix up 0.8%, also enjoying support from gains Friday in the U.S. After data showing exports grew less than analysts had projected, the dollar (USDJPY) moved back above the 98-yen level, sending some exporters climbing, with a 2.2% rise for Fujitsu Ltd. (JP:6702) (FJTSY) , a 1.2% improvement for Alps Electric Co. (JP:6770) , and a 1% bump for Toyota Motor Corp. (JP:7203) (TM) . Shares of Suzuki Motor Corp. (JP:7269) (SZKMF) added 2.9% after a Nikkei report saying the company would record its highest-ever operating profit for the April-September half. Retailers were also a strong spot Monday, with J. Front Retailing Co. (JP:3086) up 2%, online marketplace Rakuten Inc. (JP:4755) (RKUNF) adding 2.4%, and 7-Eleven operator Seven & I Holdings Co. (JP:3382) (SVNDF) ahead by 1.4%.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks weakened in early Thursday trading as the yen rose and Wall Street ended mixed, with the Nikkei Stock Average (JP:NIK) falling 1.2% to 15,929.74 after a 1.9% advance a day earlier. With the yen (USDJPY) slightly firmer than in the previous session, some investors sold currency-sensitive exporters, with Fanuc Corp. (JP:6954) (FANUF) down 2%, Kyocera Corp. (JP:6971) (KYOCF) off 1.9%, and Fujitsu Ltd. (JP:6702) (FJTSY) losing 2.3%. News that China would lift a ban on some sales of videogame consoles had sent shares of Nintendo Co. (JP:7974) (NTDOF) shooting 11% higher on Wednesday, but apparent profit-taking sent the stock down 4.2% in early Thursday action. Shares of rival Sony Corp. (JP:6758) (SNE) , however, followed with a 4% rise, also possibly buoyed by a Nikkei Asian Review report that it was planning a "smartphone offensive" in the U.S. and China. Canon Inc. (JP:7751) (CAJ) fell 2% on a separate Nikkei report that the company's 2013 operating profit would miss forecasts. Toshiba Corp. (JP:6502) (TOSYY)
No comments:
Post a Comment